Dr. Christopher Mark Smith

Dr. Christopher Mark Smith (DR. CHRISTOPHER MARK SMITH ) is A Dermatology Physician in Broomfield, CO. The NPI Number for Dr. Christopher Mark Smith is 1952393829.

The current location address for Dr. Christopher Mark Smith is 13605 XAVIER LN SUITE B Broomfield, CO 80020 and the contact number is 3034043376 and fax number is 3034399044. The mailing address for Dr. Christopher Mark Smith is 13605 XAVIER LN SUITE B Broomfield, CO 80020- 3034043376 (mailing address contact number - 3034043376).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Dr. Christopher Mark Smith ?

Answer: The NPI Number for Dr. Christopher Mark Smith is 1952393829

Where is Dr. Christopher Mark Smith located?

Answer: Dr. Christopher Mark Smith is located at 13605 XAVIER LN SUITE B Broomfield, CO 80020.

What is the specialty for Dr. Christopher Mark Smith ?

Answer: The Specialty of Dr. Christopher Mark Smith is A Dermatology Physician.

Are there any online reviews for Dr. Christopher Mark Smith ?

Answer: Yes! Check It Now.

Are there any other health care providers in Broomfield, CO?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Christopher Mark Smith

Number of HCPCS	91
Number of Medicare Beneficiaries	434
Number of Services	2632
Total Submitted Charge Amount	715437.02
Total Medicare Allowed Amount	305028.9
Total Medicare Payment Amount	228767.11
Total Medicare Standardized Payment Amount	219830.3
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	74
Number of Beneficiaries Age Less 65	22
Number of Beneficiaries Age 65 to 74	220
Number of Beneficiaries Age 75 to 84	142
Number of Beneficiaries Age Greater 84	50
Number of Female Beneficiaries	221
Number of Male Beneficiaries	213
Number of Non-Hispanic White Beneficiaries	394
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries	0
Number of Beneficiaries With Race Not Elsewhere Classified	25
Number of Beneficiaries With Medicare & Medicaid Entitlement	23
Number of Beneficiaries With Medicare Only Entitlement	411
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.09
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.06
Percent (%) of Beneficiaries Identified With Asthma	0.05
Percent (%) of Beneficiaries Identified With Cancer	0.1
Percent (%) of Beneficiaries Identified With Heart Failure	0.09
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.21
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.05
Percent (%) of Beneficiaries Identified With Depression	0.15
Percent (%) of Beneficiaries Identified With Diabetes	0.15
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.44
Percent (%) of Beneficiaries Identified With Hypertension	0.47
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.26
Percent (%) of Beneficiaries Identified With Osteoporosis	0.11
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.37
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke	0.03
Average HCC Risk Score of Beneficiaries	0.9569

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	324
Number of Standardized 30-Day Fills	364.96666667
Aggregate Cost Paid for All Claims	45052.42
Number of Day's Supply for All Claims	7704
Number of Medicare Beneficiaries	165
Number of Claims, Including Refills, for Beneficiaries Age 65+	313
Including Refills, for Beneficiaries Age 65+	353.96666667
Beneficiaries Age 65+	37758.32
Number of Day's Supply for All Claims for Beneficaries Age 65+	7457
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	314
Aggregate Cost Paid for Generic Drugs	10335.38
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	139
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	31609.35
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	185
Aggregate Cost Paid for Claims Filled by	13443.07
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	20
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	6751
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	304
by Low-Income Subsidy	38301.42
Total Claims of Opioid Drugs, Including	45
Aggregate Cost Paid for Opioid Drugs	176.88
Opioid Claims	37
Opioid_Tot_Clms divided by the Tot_Clms	13.888888889
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the	0
Total Claims of Antibiotic Drugs, Including	18
Aggregate Cost Paid for Antibiotic Drugs	272.48
Antibiotic Claims	14
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	74.278787879
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	70
Number of Male Beneficiaries	95
Number of Non-Hispanic White	154
Number of Black or African American	0
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.1763489523